MRI-Guided Laser Induced Thermal Therapy

Last updated: May 20, 2014
Sponsor: Rutgers, The State University of New Jersey
Overall Status: Terminated

Phase

N/A

Condition

Brain Cancer

Cancer/tumors

Brain Tumor

Treatment

N/A

Clinical Study ID

NCT01515085
0220110114
  • Ages > 18
  • All Genders

Study Summary

Does MR-guided laser interstitial thermal therapy (MRgLITT) prior to chemotherapy and/or radiation give patients a beneficial increase in overall survival? Laser induced thermal therapy (LITT) is a minimally invasive procedure for destroying tissue through generation of heat.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subjects that have/will undergo MRgLITT for inoperable brain tumor.

  • Tumor size < 3cm in transverse diameter for each planned applicator placement.

  • Tumor size < 4 cm in largest dimension.

  • Lesion(s) are clearly defined on pre-therapy contrast enhanced MRI scans as determinedby the treating surgeon.

  • Karnofsky Performance Scale score > 70.

  • ECOG performance status of 2 or better.

  • Biopsy proven histologic diagnosis of malignant glioma.

Exclusion

Exclusion Criteria:

  • Patients with co-existing medical conditions with life expectancy < 1 year.

  • Patients having received pre-ablation chemotherapy and/or radiation to lesion.

Study Design

Total Participants: 1
Study Start date:
August 01, 2011
Estimated Completion Date:
June 30, 2012

Study Description

Laser induced thermal therapy (LITT) is a procedure for destroying tissue through generation of heat. When used in conjunction with fiberoptic applicators, it offers an excellent means of minimally invasive surgery. As opposed to other thermal techniques like radio-frequency (RF) ablation, or cryo-ablation, LITT may be significantly faster and may exhibit sharper boundary of the thermal ablation zone. More importantly, LITT is highly compatible with MR imaging and when coupled with MR thermal imaging (MRTI) guidance, precise monitoring of the thermal ablation zone in order to avoid eloquent or critical structures is possible.

In this study, we propose to evaluate MR-thermal image guided laser interstitial therapy for the treatment of inoperable brain tumors as upfront therapy prior to initiation of chemotherapy and radiation. MR-thermal imaging (MRTI) will be used to provide information on thermal dose delivered to the target and be used to control laser delivery to prevent damage to critical structures.

Connect with a study center

  • Robert Wood Johnson University Hospital

    New Brunswick, New Jersey 08901
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.